Literature DB >> 6971042

Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukemia in Norway. Preliminary results of a national treatment program.

P J Moe, M Seip, P H Finne.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6971042     DOI: 10.1111/j.1651-2227.1981.tb07176.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


× No keyword cloud information.
  7 in total

1.  Survival and endocrine outcome after testicular relapse in acute lymphoblastic leukaemia.

Authors:  R G Grundy; A D Leiper; R Stanhope; J M Chessells
Journal:  Arch Dis Child       Date:  1997-03       Impact factor: 3.791

2.  Cranial irradiation in childhood lymphoblastic leukemia: time for reappraisal.

Authors:  J M Chessells
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-14

3.  7-Hydroxymethotrexate concentrations in serum and cerebrospinal fluid of children with acute lymphoblastic leukemia.

Authors:  J D Borsi; E Sagen; I Romslo; L Slørdal; P J Moe
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

4.  Prognostic importance of systemic clearance of methotrexate in childhood acute lymphoblastic leukemia.

Authors:  J D Borsi; T Revesz; D Schuler
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

5.  Medical cost of curing childhood acute lymphoblastic leukaemia.

Authors:  K Wheeler; A D Leiper; L Jannoun; J M Chessells
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-16

Review 6.  Childhood acute lymphoblastic leukaemia: a review.

Authors:  M L Willoughby
Journal:  J R Soc Med       Date:  1982-06       Impact factor: 18.000

7.  Reproduction and marriage among male survivors of cancer in childhood, adolescence and young adulthood: a national cohort study.

Authors:  M W Gunnes; R T Lie; T Bjørge; S Ghaderi; E Ruud; A Syse; D Moster
Journal:  Br J Cancer       Date:  2016-01-21       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.